Study of Some Biochemical Parameters and Fatty Acids Composition in Blood Serum of Women with Polycystic Ovary Syndrome

Yıl 2018, Sayı: 2, 151 - 158, 19.08.2018

Abd-alkream H.ısmaıl Mohamed A.h.jasım Shaima’a A.h.jasım

Öz

This study was 
designed to compare the level of some biochemical parameters and lipid
fractions and percentage of fatty acids in serum of women with Polycystic ovary
syndrome (PCOS) ,the study include (25)  patients(females) who were diagnosed by
ultrasonography , the sample collection is from 
Al-Bitol  teaching hospital in
Mosul city, the age is between (25-40) year and compared with (25) normal woman
with same age were collected as control and measurement of a number of
biochemical parameters in serum  ,as well
as analysis and measurement of percentage of fatty acids in the fatty component
of serum  (cholesterol ester ,
phospholipids and triglyceride ) by applying thin layer chromatography (TLC)
and then re-esterfication fatty acids and measurement percentage of fatty acids
applying capillary gas chromatography (CGC) . the result of this study show
that there is a significant differences in the level of studied  biochemical parameter and fatty acids
percentage in  patients compared with the
control group.

Anahtar Kelimeler

Biochemical parameters, Blood serum

Kaynakça

• Desloover S. Ernst M.Use of metformin in polycystic ovary syndrome. Annals of Pharmacotherapy 35.(2001). Witchel S. Arslanian S. Ovarian responses to HCG stimulation .clin. Endocrinal 51 .(1999). Goldzieher J. Green J. Clinical and biochemical features of polycystic ovary disease . fertile steril 14 .(1993). Elting M. Korsen T. Schoemaker J. Woman with PCOS gain regular menstrual cycles when ageing . Hum. Report 15.(2000). Rai R. Backos M. Regan L. Polycystic ovaries and recurrent miscarriage .Hem .Report 15.(2000). Murray R., Grammar D. Harper's Biochemistry 25th ed .,Appleton and Lange, USA, (2000). Charnvises K. Weerakiet S. Wansumrith S. Acanthosis nigricans clinical predictor of abnormal glucose tolerance in Asian woman with PCOS. Gynecol. Endocrinol ,(2005). Burtis C, Ashwood E. Tiets Text Book of Clinical Chemistry.3red. W.B.Saunders Com.:pp110-115.(1999) Kosnor G.M. Enzymatic determination cholesterol in HDL fraction .Clin.Chem.;22:665-670.(1976) Michael L, Edward P, Larry S. Clinical Chemistry .5th Williams &Wilkins. ; pp.288-292.(2005) Tietz N. Text Book of Clinical Biochemistry .W.B. Saunders Com. Philadelphia,USA;135-140.(1986) Ma J. Shahar E. Plasma fatty acids composition in middle-age adults. Am.J.Clin. Nutr.;62:564-571.(2005) Leonard T. Kathleen R. The ways and means of statistics. Harcourt Brace Jovanovich.;pp490-495. (1979) Dunaif A. Insulin resistance in PCOS. Ann. Acad. Sci 687.(1993). Peppard H. Marfori J. Nestler J. Prevalence of PCOS among woman with type 2 diabetes .Dia.Care 24.(2001). Marx T. Mehta A. Polycystic ovary syndrome: pathogenesis and termentover the short and long term. Clin.J.Medic.70.(2003). Dunaif A. Insulin resistance and the PCOS :mechanism and implications for pathogenesis .Endocrinol Rev.18.(1997). Ledinghamn J. Warell D. Concise oxford textbook of medicine .Oxford (2000). Juvonen T. Lajunen H. Polymorphisms CETP gene loci in woman with PCOS .J. lipids Res.36:804-812.(1995) Karen K. Kunt B. and Jan S. Transvascular LDL-C transport in patients with NIDDM. Arteriosclerosis;22:1168.(2002) Eduardas A. Nadežda L. Laura S. Multiple primary cancers: a case of successful treatment . acta medica lituanica. vol. 16. P. 47–51. (2009). Kapoor D. Jones T. Smoking and hormones in health and endocrine disorders . Euro. J. of Endocrinology. 152. 491–499 (2005). Anders C. E . A Geographical Analysis of Preventative Dietary Micronutrients :The Vancouver Island Hereditary Brest and Ovarian Cancer Research. Uni. of Victoria. (2004). Murray R. Gramner D and Rodweu W. Harper,s Biochemistry 25th ed .Appleton and Lange ,USA :150-160.(1996) Al-Tamer Y. and Al-Juraisy A. Lipids component and fatty acid composition of Iraqi subjects who smoke and consume dairy products .Nurt. Metab. Cardiovasc. Dis.14:94-96.(2004) Mohr G. Kritz D. and Barret E. Plasma lipids and PCOS disease .Am. J .Epidemiol.,134:78-85.(1991) Scragg R. and Oliver J. Plasma lipids and insulin in PCOS disease. Br.Med.J.289:521-525.(1984) Cate S. and Helsu D. Trans fatty acids increase the risk factor of gallstone and PCOS disease .General Health News .(2005) Vessby B., Boberg M. and Andersson A. Desaturation and elongation of fatty acids and insulin action. Annals. of New York Academy of Sci., 967: 183-195.(2002) Shuo D. Kazuhisa U. and Ying F. The role and mechanism of fatty acids in some disease . Hepatobiliary pancreat Dis. Int.4:399-402.(2007)